Dr Martin Lombard of the Royal Liverpool and Broadgreen University Hospitals has been appointed National Clinical Director for Liver Disease.
Dr Lombard, a Consultant Hepatologist, will take up the new role on 18 January, leading the development of a National Liver Strategy for England.
The strategy will bring together NHS services and builds on the Department of Health's commitment to tackle the growing levels of liver disease.
Liver disease is now one of the most common causes of death in England and if action is not taken to combat the disease, it could overtake stroke and coronary heart disease as a cause of death within the next 10 to 20 years.
The growth in liver disease is largely fuelled by lifestyle factors such as excessive drinking, risk taking behaviour leading to transmission of Hepatitis C, and obesity.
Dr Lombard is Clinical Director of Gastroenterology and Liver Services at the Royal Liverpool and Broadgreen University Hospitals.
He chairs the National Training Committee for Gastroenterology; and chairs the Mersey Region Cancer Network group for liver and pancreas cancers.
said: "The burden of liver disease has increased enormously in the past 10 to 15 years and unfortunately is an increasing cause of death in younger patients.
is a highly-respected clinical expert in this field and I am pleased to welcome him to the Department to lead our National Liver Strategy
"I am confident that Dr Lombard
will build on the work already underway to make a real difference for patients and for the healthcare staff working in this area."
Dr Lombard will remain active in clinical medicine and will continue to work part-time at the Royal Liverpool and Broadgreen University Hospitals NHS Trust.